Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Medbook World, IncFinancial_Report.xls
10-K - FORM 10K - Medbook World, Incmedbook9302012_10k.htm
XML - IDEA: XBRL DOCUMENT - Medbook World, IncR7.htm
XML - IDEA: XBRL DOCUMENT - Medbook World, IncR4.htm
XML - IDEA: XBRL DOCUMENT - Medbook World, IncR2.htm
XML - IDEA: XBRL DOCUMENT - Medbook World, IncR3.htm
XML - IDEA: XBRL DOCUMENT - Medbook World, IncR1.htm
XML - IDEA: XBRL DOCUMENT - Medbook World, IncR9.htm
XML - IDEA: XBRL DOCUMENT - Medbook World, IncR8.htm
XML - IDEA: XBRL DOCUMENT - Medbook World, IncR6.htm
XML - IDEA: XBRL DOCUMENT - Medbook World, IncR25.htm
XML - IDEA: XBRL DOCUMENT - Medbook World, IncR10.htm
XML - IDEA: XBRL DOCUMENT - Medbook World, IncR13.htm
XML - IDEA: XBRL DOCUMENT - Medbook World, IncR17.htm
XML - IDEA: XBRL DOCUMENT - Medbook World, IncR19.htm
XML - IDEA: XBRL DOCUMENT - Medbook World, IncR15.htm
XML - IDEA: XBRL DOCUMENT - Medbook World, IncR21.htm
XML - IDEA: XBRL DOCUMENT - Medbook World, IncR12.htm
XML - IDEA: XBRL DOCUMENT - Medbook World, IncR18.htm
XML - IDEA: XBRL DOCUMENT - Medbook World, IncR20.htm
XML - IDEA: XBRL DOCUMENT - Medbook World, IncR22.htm
XML - IDEA: XBRL DOCUMENT - Medbook World, IncR16.htm
XML - IDEA: XBRL DOCUMENT - Medbook World, IncR14.htm
XML - IDEA: XBRL DOCUMENT - Medbook World, IncR23.htm
XML - IDEA: XBRL DOCUMENT - Medbook World, IncR24.htm
XML - IDEA: XBRL DOCUMENT - Medbook World, IncR11.htm
EX-32 - EXHIBIT 32 - Medbook World, Incexhibit32_ex32.htm
EX-31.1 - EXHIBIT 31.1 - Medbook World, Incexhibit311_ex31z1.htm
EX-31.2 - EXHIBIT 31.2 - Medbook World, Incexhibit312_ex31z2.htm
v2.4.0.6
Statement of Shareholders' Equity and Other Comprehensive Income (USD $)
Common Stock
Additional Paid-in Capital
Retained Earnings
Total
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest at Nov. 30, 2009     $ (66,345)  
Shares, Outstanding at Nov. 30, 2009       11,150,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest     (2,500) (2,500)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest at Sep. 30, 2010 1,115 65,230 (68,845) (2,500)
Shares, Outstanding at Sep. 30, 2010 11,150,000     11,150,000
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest at Nov. 16, 2009        
Stock Issued During Period, Value, New Issues 1,115 10,715   11,830
Stock Issued During Period, Shares, New Issues 11,150,000      
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest     (66,345) (66,345)
Stockholders' Equity, Other   54,515   54,515
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest at Nov. 30, 2009 1,115 65,230 (66,345)  
Shares, Outstanding at Nov. 30, 2009 11,150,000     11,150,000
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest at Sep. 30, 2010 1,115 65,230 (68,845) (2,500)
Shares, Outstanding at Sep. 30, 2010 11,150,000     11,150,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest     (48,059) (48,059)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest at Sep. 30, 2011 1,115 65,230 (116,904) (50,559)
Shares, Outstanding at Sep. 30, 2011 11,150,000     11,150,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest     (64,247) (64,247)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest at Sep. 30, 2012 $ 1,115 $ 65,230 $ (181,151) $ (114,806)
Shares, Outstanding at Sep. 30, 2012 11,150,000     11,150,000